Targeting CDCA3 Enhances Sensitivity to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Adams, M. [1 ]
Burgess, J. [1 ]
Richard, D. [1 ]
O'Byrne, K. [2 ]
机构：
[1] Inst Hlth & Biomed Innovat, Translat Res Inst, Woolloongabba, Qld, Australia
[2] Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
non-small cell lung cancer; prognostic factor; cisplatin chemotherapy;
D O I：
10.1016/j.jtho.2017.09.468
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 03.11
引用
收藏
页码：S1810 / S1811
页数：2
相关论文
共 50 条
  • [1] Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
    Kildey, Katrina
    Gandhi, Neha S.
    Sahin, Katherine B.
    Shah, Esha T.
    Boittier, Eric
    Duijf, Pascal H. G.
    Molloy, Christopher
    Burgess, Joshua T.
    Beard, Sam
    Bolderson, Emma
    Suraweera, Amila
    Richard, Derek J.
    O'Byrne, Kenneth J.
    Adams, Mark N.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [2] Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
    Katrina Kildey
    Neha S. Gandhi
    Katherine B. Sahin
    Esha T. Shah
    Eric Boittier
    Pascal H. G. Duijf
    Christopher Molloy
    Joshua T. Burgess
    Sam Beard
    Emma Bolderson
    Amila Suraweera
    Derek J. Richard
    Kenneth J. O’Byrne
    Mark N. Adams
    Communications Biology, 4
  • [3] CDCA3 regulates the cell cycle and modulates cisplatin sensitivity in non-small cell lung cancer
    O'Byrnel, K.
    Adams, M.
    Burgess, J.
    Richard, D.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S65 - S65
  • [4] Enhancing sensitivity to platinum-based therapy by suppressing the novel prognostic factor CDCA3 in nonsmall cell lung cancer
    Adams, M.
    Burgess, J.
    Richard, D.
    O'Byrne, K.
    LUNG CANCER, 2019, 127 : S2 - S2
  • [5] Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Angel Molina, Miguel
    Robles, Ana I.
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2017, 771 : 32 - 58
  • [6] Bevacizumab Plus Platinum-Based Chemotherapy In Advanced Non-Small Cell Lung Cancer
    Wagstaff, Antona J.
    Keam, Susan J.
    McCormack, Paul L.
    BIODRUGS, 2009, 23 (03) : 187 - 196
  • [7] CDCA3 is a Novel Prognostic Cell Cycle Protein and Target for Therapy in Non-Small Cell Lung Cancer
    Adams, Mark
    Burgess, Joshua
    Gately, Kathy
    Snell, Cameron
    Richard, Derek
    O'Byrne, Kenneth
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S837 - S837
  • [8] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Hirotsugu Kenmotsu
    Tateaki Naito
    Keita Mori
    Ryo Ko
    Akira Ono
    Kazushige Wakuda
    Hisao Imai
    Tetsuhiko Taira
    Haruyasu Murakami
    Masahiro Endo
    Toshiaki Takahashi
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 521 - 526
  • [9] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Mori, Keita
    Ko, Ryo
    Ono, Akira
    Wakuda, Kazushige
    Imai, Hisao
    Taira, Tetsuhiko
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 521 - 526
  • [10] Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer
    Adams, Mark N.
    Burgess, Joshua T.
    He, Yaowu
    Gately, Kathy
    Snell, Cameron
    Zhang, Shu-Dong
    Hooper, John D.
    Richard, Derek J.
    O'Byrne, Kenneth J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1071 - 1084
12345